Fig. 3From: Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patientsDisplays the four HRQL scales in comparison between the three subgroups. No differences could be detected. AATD = Alpha-1-antitrypsin deficiency, AAT = augmentation therapyBack to article page